F707-2556 Screening compound: 1-{1-[3-(4-methylphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidine-4-carbonyl}-4-(pyridin-2-yl)piperazine

F707-2556 Screening compound: 1-{1-[3-(4-methylphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidine-4-carbonyl}-4-(pyridin-2-yl)piperazine
F707-2556 Screening compound: 1-{1-[3-(4-methylphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidine-4-carbonyl}-4-(pyridin-2-yl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound F707-2556
1-{1-[3-(4-methylphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidine-4-carbonyl}-4-(pyridin-2-yl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F707-2556

Molecular Formula

C27H30N8O (C27 H30 N8 O)

Compound Name

1-{1-[3-(4-methylphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidine-4-carbonyl}-4-(pyridin-2-yl)piperazine

IUPAC name

1-{1-[3-(4-methylphenyl)-[124]triazolo[43-b]pyridazin-6-yl]piperidine-4-carbonyl}-4-(pyridin-2-yl)piperazine

SMILES

Cc(cc1)ccc1-c1nnc(cc2)n1nc2N(CC1)CCC1C(N(CC1)CCN1c1ncccc1)=O

InChI

InChI=1S/C27H30N8O/c1-20-5-7-21(8-6-20)26-30-29-24-9-10-25(31-35(24)26)32-14-11-22(12-15-32)27(36)34-18-16-33(17-19-34)23-4-2-3-13-28-23/h2-10,13,22H,11-12,14-19H2,1H3

InChI Key

KDNBPKZPVVCUNF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27186413

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

482.59

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.014

Distribution Coefficient, logD

4.005

Water Solubility, LogSw

-4.03

Polar Surface Area

63.733

Acid Dissociation Constant (pKa)

22.16

Base Dissociation Constant (pKb)

5.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.00

F707-2556 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F707-2556 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F707-2556?
Check Price and Availability of F707-2556, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F707-2556 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F707-2556
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F707-2556
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F707-2556 available by request